Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice

Neuropsychopharmacology

Volumn 29, Issue 6, 2004, Pages 1122-1133

  Valverde, Olga ^a   Mantamadiotis, Theo ^b,d   Torrecilla, María ^c   Ugedo, Luisa ^c   Pineda, Joseba ^c   Bleckmann, Susanne ^b   Gass, Peter ^b   Kretz, Oliver ^b   Mitchell, Jennifer M ^a   Schütz, Günther ^b   Maldonado, Rafael ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Conditioned place preference; CREB; Emotional behavior; Knockout mice; Locus coeruleus; Opiate addiction

Indexed keywords

COCAINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ISOPROTEIN; MORPHINE; PROTEIN SUBUNIT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FOOD; LOCUS CERULEUS; MORPHINE ADDICTION; MOTIVATION; MOUSE; NEUROMODULATION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD;

ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EXPLORATORY BEHAVIOR; IMMUNOHISTOCHEMISTRY; LOCUS COERULEUS; MAZE LEARNING; MICE; MICE, KNOCKOUT; MORPHINE DEPENDENCE; MOTOR ACTIVITY; PROTEIN ISOFORMS; REACTION TIME; SPATIAL BEHAVIOR; TIME FACTORS;

EID: 2542482845     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300416     Document Type: Article

References (50)

1. Barrot M, Olivier JDA, Perrotti LI, DiLeone RJ, Berton O, Eisch AJ et al (2002). CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci USA 99: 11435-11440.
2. Bell JA, Grant CJ (1998). Locus coeruleus neurons from morphine-treated rats do not show opiate-withdrawal hyperactivity in vitro. Brain Res 788: 237-244.
3. Berke JD, Hyman SE (2000). Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25: 515-532.
4. Blendy JA, Kaestner KH, Schmid W, Gass P, Schutz G (1996b). Targeting of the CREB gene leads to up-regulation of a novel CREB mRNA isoform. EMBO J 15: 1098-1106.
5. Blendy JA, Kaestner KH, Weinbauer GF, Nieschlag E, Schutz G (1996a). Severe impairment of spermatogenesis in mice lacking the CREM gene. Nature 380: 162-165.
6. Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G, Silva AJ (2002). Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79: 59-68.
7. Britton KT, Svensson T, Schwartz J, Bloom FE, Koob GF (1984). Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine. Life Sci 34: 133-139.
8. Caille S, Espejo EF, Reneric JP, Cador M, Koob GF, Stinus L (1999). Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp Ther 290: 881-892.
9. Carlezon Jr WA, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N et al (1998). Regulation of cocaine reward by CREB. Science 282: 2272-2275.
10. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2002). Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403: 430-434.
11. Di Chiara G, North RA (1992). Neurobiology of opiate abuse. Trends Pharmacol Sci 13: 185-193.
12. Graves L, Dalvi A, Lucki I, Blendy JA, Abel T (2002). Behavioral analysis of CREBαΔ mutation on a B6/129 F1 hybrid background. Hippocampus 12: 18-26.
13. Guitart X, Thompson MA, Mirante CK, Greenberg ME, Nestler EJ (1992). Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J Neurochem 58: 1168-1171.
14. Hummler E, Cole TJ, Blendy JA, Ganss R, Aguzzi A, Schmid W et al (1994). Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. Proc Natl Acad Sci USA 91: 5647-5651.
15. Josselyn SA, Kida S, de Ortiz P, Silva AJ (2002). CREB, plasticity and memory. In: Kaczmarek L, Robertson HA (eds) Handbook of Chemical Neuroanatomy: Immediate Early Genes and Inducible Transcription Factors in Mapping of the Central Nervous System Function and Dysfunction. Elsevier. Amsterdam.
16. Kaspar BK, Lladó J, Sherkat N, Rothstein JD, Gage FH (2003). Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301: 839-842.
17. Kelz MB, Nestler EJ (2000). ΔfosB: a molecular switch underlying long-term neural plasticity. Curr Opin Neurol 13: 715-720.
18. Kinney BA, Meliska CJ, Steger RW, Bartke A (2001). Evidence that Ames dwarf mice age differently from their normal siblings in behavioral and learning and memory parameters. Horm Behav 39: 277-284.
19. Kogan JH, Nestler EJ, Aghajanian GK (1992). Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur J Pharmacol 211: 47-53.
20. König M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ et al (1996). Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383: 535-538.
21. Koob GF, Le Moal M (1997). Drug abuse: hedonic homeostatic dysregulation. Science 278: 52-58.
22. Koob GF, Sanna PP, Bloom FE (1998). Neuroscience of addiction. Neuron 21: 467-476.
23. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK et al (1997). CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17: 7890-7901.
24. Lonze BE, Riccio A, Cohen S, Ginty DD (2002). Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron 34: 371-385.
25. Maldonado R, Blendy JA, Tzavara E, Gass P, Roques BP, Hanoune J et al (1996). Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273: 657-659.
26. Maldonado R, Koob GF (1993). Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res 605: 128-138.
27. Maldonado R, Negus S, Koob GF (1992a). Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Neuropharmacology 31: 1231-1241.
28. Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borrelli E (1997). Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388: 586-589.
29. Maldonado R, Smadja C, Mazzucchelli C, Sassone-Corsi P, Mazucchelli C (1999). Altered emotional and locomotor responses in mice deficient in the transcription factor CREM. Proc Natl Acad Sci USA 96: 14094-14099.
30. Maldonado R, Stinus L, Gold LH, Koob GF (1992b). Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261: 669-677.
31. Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, Villalba AM et al (2002). Disruption of CREB function in brain leads to neurodegeneration. Nat Genet 31: 47-54.
32. Mantamadiotis T, Taraviras S, Tronche F, Schutz G (1998). PCR-based strategy for genotyping mice and ES cells harboring loxP sites. Biotechniques 25: 968-970; 972.
33. Mayr B, Montminy M (2001). Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609.
34. Nestler EJ (1997). Molecular mechanisms of opiate and cocaine addiction. Curr Opin Neurobiol 7: 713-719.
35. Nestler EJ (2001). Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119-128.
36. Nestler EJ, Aghajanian GK (1997). Molecular and cellular basis of addiction. Science 278: 58-63.
37. Nestler EJ, Barrot M, Dileone SJ, Eisch AJ, Gold SJ, Monteggia LM (2002). Neurobiology of depression. Neuron 34: 13-25.
38. Nestler EJ, Hope BT, Widnell KL (1993). Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11: 995-1006.
39. Nibuya M, Nestler EJ, Duman RS (1996). Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16: 2365-2372.
40. NIH (1985). Guide for Care and Use of Laboratory Animals, no. 82-85.
41. Pandey SC (2003). Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol Sci 24: 456-460.
42. Pandey SC, Roy A, Zhang H (2003). The decreased phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats. Alcoholism: Clin Exp Res 27: 396-409.
43. Rasmussen K, Aghajanian GK (1989). Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis. Brain Res 505: 346-350.
44. Rasmussen K, Beitner Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ (1990). Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci 10: 2308-2317.
45. Rudolph D, Tafuri A, Gass P, Hammerling GJ, Arnold B, Schutz G (1998). Impaired fetal T cell development and perinatal lethality in mice lacking the cAMP response element binding protein. Proc Natl Acad Sci USA 95: 4481-4486.
46. Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S et al (2000). cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 20: 2404-2412.
47. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC et al (1999). Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23: 99-103.
48. Valverde O, Smadja C, Roques BP, Maldonado R (1997). The attenuation of morphine-conditioned place preference following chronic mild stress is reversed by a CCKB receptor antagonist. Psychopharmacology 131: 79-85.
49. Walters CL, Blendy JA (2001). Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J Neurosci 21: 9438-9444.
50. Willner P (1990). Animal models of depression: an overview. Pharmacol Ther 45: 425-455.